Toft Group Opens In San Francisco
April 5, 2016 – Toft Group, an executive search firm focusing exclusively on the life sciences and healthcare sectors, has opened a new office in the San Francisco Bay Area to support continued growth and customer demand.
The new office is strategically situated in South San Francisco, among neighboring biotech, pharmaceutical, medical device, and digital health companies.
According to the San Francisco Bay Area Professional Employment Forecast from Robert Half, 52 percent of San Francisco Bay Area executives say it is ‘somewhat’ or ‘very challenging’ to find skilled candidates for professional-level positions; 77 percent of hiring managers plan to hire for open roles in the next six months.
“Our new location in the heart of one of the world’s top biotech communities aligns with our commitment to deliver higher quality candidates more quickly than other firms, thereby enabling our customers to commercialize their novel products faster for the benefit of patients worldwide,” said founder and CEO Robin Toft (pictured).
According to recruiters, highly skilled candidates are in great demand throughout the San Francisco Bay Area, and they often receive multiple job offers with competitive compensation packages. As a result, there is growing demand for professional level candidates in accounting, finance, administration and technology.
Toft Group recently hired David Felker as senior vice president of executive search and Gabriela Tobal as VP of business development. Both are leading the expansion of Toft Group’s pharmaceutical sector search practice.
This expansion follows the launch of the firm’s dedicated digital health & healthcare IT search practice. This new specialized team is focused on executive and niche technical searches for digital health companies, including SaaS, PaaS, big data & analytics, mobile health, genomics, personalized medicine, patient engagement, population health management, and digital medical device companies.
Toft Group specializes in searches for organizations in biotech, pharmaceutical, medical device, and diagnostics.
Contributed by Dale M. Zupsansky, Managing Editor, Hunt Scanlon Media
